We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
ACCEPT Reject
Already have an account? Sign in.

 Remember Me | Forgot Your Password?
Home Manage Alerts Archive Archive About Us Register Now   Not a User? Join now

Nestlé Strides Into Clinical Nutrition Market With Acquisition of Vitaflo

August 2, 2010: 10:34 AM EST
With the acquisition of U.K.-based Vitaflo, Nestlé has taken a big step into the mushrooming global market for clinical nutrition products for people with inherited metabolic disorders. According to Nestlé, Vitaflo has annual sales of about $39 million and a growth rate of 30% over the last three years, as improved diagnosis and screening are detecting more cases. In addition, scientific advances demonstrate the benefits of specialized nutrition as an integral part of clinical management. The company’s products are targeted at infants, children and adults with genetic disorders that affect how food is processed by the body, including phenylketonuria (PKU), maple syrup urine disease (MSUD) and homocystinuria (HCU).
"Nestlé to enter fast-growing global market for clinical nutrition products for people with inherited metabolic disorders", Nestle press release, August 02, 2010, © Société des Produits Nestlé S.A
Domains
TrendSpotter
Vitality & Better Living
Geographies
Worldwide
EMEA
Europe
United Kingdom
Categories
Companies, Organizations
Deals, M&A, JVs, Licensing
Market News
Products & Brands
Home | Privacy Policy | Terms and Conditions | Contact Us Copyright © 2000-2023 Business360 Inc. All Rights Reserved
Developed by Yuri Ingultsov Software Lab.